The FDA has approved adaptive deep brain stimulation (aDBS), a breakthrough therapy that adjusts in real time to Parkinson’s disease symptoms.
The Food and Drug Administration on Monday granted its first approval for a pacemaker-like device for the brain to ease ...
Starting today, people with Parkinson's disease will have a new treatment option, thanks to U.S. Food and Drug Administration approval of groundbreaking new technology.
Among 13,711 matched pairs, GLP-1 receptor agonist users had a 10% lower risk for depression compared with DPP-4 inhibitor ...
St John of God Hospital in Dublin has said it is the first hospital in Ireland to introduce a special treatment for patients ...